pharmaceuticals-and-healthcare

Global Follicle Stimulating Hormone Market by Manufacturers, Regions, Type and Application, Forecast to 2023


Published On : Sep 2017

Category : Biotechnology

No. of Pages : 134 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  

This report studies the follicle stimulating hormone market.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU.
Scope of the Report
This report focuses on the Follicle Stimulating Hormone in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
?Merck Serono
?MSD
?IBSA
?Ferring
?Livzon
?Techwell
?GenSci
?Gedeon Richter
?Teva

Market Segment by Regions, regional analysis covers
?North America (United States, Canada and Mexico)
?Europe (Germany, France, UK, Russia and Italy)
?Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
?South America (Brazil, Argentina, Colombia)
?Middle East and Africa (Saudi Arabia, UAE, Egypt, Israel and South Africa)

Market Segment by Type, covers
?Recombinant FSH
?Urinary FSH

Market Segment by Applications, can be divided into
?Infertility Treatment
?Assisted Reproductive Technology

 

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The Global follicle stimulating hormone market by manufacturers regions type and application forecast to 2023 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the Global follicle stimulating hormone market by manufacturers regions type and application forecast to 2023 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the Global follicle stimulating hormone market by manufacturers regions type and application forecast to 2023 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

List of Tables and Figures

Figure Follicle Stimulating Hormone Picture1
Table Product Specifications of Follicle Stimulating Hormone1
Figure Global Sales Market Share of Follicle Stimulating Hormone by Types in 20163
Table Comparison of Recombinant DNA FSH and Urine Extraction FSH3
Table Global Major Suppliers with Product Types and Market Time3
Figure Recombinant FSH Picture5
Figure Urinary FSH Picture5
Figure Follicle Stimulating Hormone Sales Market Share by Applications in 20166
Figure United States Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)7
Figure Canada Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)8
Figure Mexico Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)9
Figure Germany Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)10
Figure France Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)11
Figure UK Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)12
Figure Russia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)13
Figure Italy Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)14
Figure China Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)15
Figure Japan Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)16
Figure Korea Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)17
Figure India Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)18
Figure Southeast Asia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)19
Figure Brazil Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)20
Figure Egypt Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)21
Figure Saudi Arabia Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)22
Figure South Africa Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)23
Figure Israel Follicle Stimulating Hormone Revenue (Value) and Growth Rate (2012-2023)24
Figure Causes of Infertility 201325
Table Merck Serono Basic Information, Manufacturing Base and Competitors26
Figure Follicle Stimulating Hormone Picture of Merck Serono27
Table Follicle Stimulating Hormone Specifications of Merck Serono27
Table Merck Serono Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)29
Table MSD Basic Information, Manufacturing Base and Competitors29
Table Follicle Stimulating Hormone Specifications of MSD30
Table MSD Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)31
Table IBSA Basic Information, Manufacturing Base and Competitors32
Figure Follicle Stimulating Hormone Picture of IBSA33
Table IBSA Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)33
Table Ferring Basic Information, Manufacturing Base and Competitors34
Figure Follicle Stimulating Hormone Picture of Ferring35
Table Ferring Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)35
Table Livzon Basic Information, Manufacturing Base and Competitors36
Figure Follicle Stimulating Hormone Picture of Livzon37
Table Follicle Stimulating Hormone Specification of Livzon38
Table Livzon Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)38
Table Techwell Basic Information, Manufacturing Base and Competitors38
Table Techwell Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)39
Table GenSci Basic Information, Manufacturing Base and Competitors40
Figure Follicle Stimulating Hormone Product Picture of GenSci40
Table GenSci Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)41
Table Gedeon Richter Basic Information, Manufacturing Base and Competitors41
Table Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)42
Table Teva Basic Information, Manufacturing Base and Competitors43
Figure Follicle Stimulating Hormone Product Picture44
Figure Ovaleap Pen? Picture45
Table Teva Follicle Stimulating Hormone Sales (K Doses), Price (USDDose), Revenue (Million USD), Gross Margin and Market Share (2016-2017)46
Table Global Follicle Stimulating Hormone Sales (K Doses) by Manufacturer (2016-2017)47
Figure Global Follicle Stimulating Hormone Sales Market Share by Manufacturer in 201648
Figure Global Follicle Stimulating Hormone Sales Market Share by Manufacturer in 201749
Table Global Follicle Stimulating Hormone Revenue (Million USD) by Manufacturer (2016-2017)49
Figure Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 201650
Figure Global Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 201751
Figure Top 3 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 201652
Figure Top 6 Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 201653
Figure Global Top 3 Suppliers Total Revenue Market Share 2012-201754
Figure Global Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)55
Figure Global Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)56
Table Global Follicle Stimulating Hormone Sales (K Doses) by Regions (2012-2017)56
Table Global Follicle Stimulating Hormone Sales Market Share by Regions (2012-2017)56
Table Global Follicle Stimulating Hormone Revenue (Million USD) by Regions (2012-2017)57
Figure Global Follicle Stimulating Hormone Revenue Market Share by Regions in 2012-201757
Figure Global Follicle Stimulating Hormone Revenue Market Share by Regions in 201658
Figure North America Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)58
Figure Europe Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)59
Figure Asia-Pacific Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)60
Figure South America Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)61
Figure Middle East and Africa Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)62
Figure North America Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)63
Table North America Follicle Stimulating Hormone Sales (K Doses) by Countries (2012-2017)63
Table North America Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)64
Figure North America Follicle Stimulating Hormone Sales Market Share by Countries in 201264
Figure North America Follicle Stimulating Hormone Sales Market Share by Countries in 201665
Table North America Follicle Stimulating Hormone Revenue (Million USD) by Countries (2012-2017)65
Table North America Follicle Stimulating Hormone Revenue Market Share by Countries (2012-2017)65
Figure North America Follicle Stimulating Hormone Revenue Market Share by Countries in 201266
Figure North America Follicle Stimulating Hormone Revenue Market Share by Countries in 201666
Figure United States Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)67
Figure Canada Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)68
Figure Mexico Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)69
Figure Europe Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)70
Table Europe Follicle Stimulating Hormone Sales (K Doses) by Countries (2012-2017)70
Table Europe Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)71
Table Europe Follicle Stimulating Hormone Revenue (Million USD) by Countries (2012-2017)71
Figure Europe Follicle Stimulating Hormone Revenue Market Share by Countries in 201272
Figure Europe Follicle Stimulating Hormone Revenue Market Share by Countries in 201672
Figure Germany Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)73
Figure UK Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)74
Figure France Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)75
Figure Russia Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)76
Figure Italy Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)77
Figure Asia-Pacific Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)78
Table Asia-Pacific Follicle Stimulating Hormone Sales (K Doses) by Countries (2012-2017)78
Table Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)79
Figure Asia-Pacific Follicle Stimulating Hormone Sales Market Share by Countries 201279
Table Asia-Pacific Follicle Stimulating Hormone Revenue (Million USD) by Countries (2012-2017)80
Table Asia-Pacific Follicle Stimulating Hormone Revenue Market Share by Countries (2012-2017)80
Figure China Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)81
Figure Japan Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)82
Figure Korea Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)83
Figure India Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)84
Figure Southeast Asia Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)85
Figure South America Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)86
Table South America Follicle Stimulating Hormone Sales (K Doses) by Countries (2012-2017)86
Table South America Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)87
Figure South America Follicle Stimulating Hormone Sales Market Share by Countries in 201687
Table South America Follicle Stimulating Hormone Revenue (Million USD) by Countries (2012-2017)87
Table South America Follicle Stimulating Hormone Revenue Market Share by Countries (2012-2017)88
Figure South America Follicle Stimulating Hormone Revenue Market Share by Countries in 201688
Figure Brazil Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)89
Figure Argentina Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)90
Figure Colombia Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)91
Figure Middle East and Africa Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2012-2017)92
Table Middle East and Africa Follicle Stimulating Hormone Sales (K Doses) by Countries (2012-2017)92
Table Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Countries (2012-2017)93
Figure Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Countries in 201693
Table Middle East and Africa Follicle Stimulating Hormone Revenue (Million USD) by Countries (2012-2017)94
Table Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Countries (2012-2017)94
Figure Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Countries in 201295
Figure Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Countries in 201695
Figure Saudi Arabia Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)96
Figure UAE Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)97
Figure Egypt Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)98
Figure Israel Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)99
Figure South Africa Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2012-2017)100
Table Global Follicle Stimulating Hormone Sales (K Doses) by Type (2012-2017)101
Table Global Follicle Stimulating Hormone Sales Share by Type (2012-2017)101
Table Global Follicle Stimulating Hormone Revenue (Million USD) by Type (2012-2017)101
Table Global Follicle Stimulating Hormone Revenue Share by Type (2012-2017)102
Figure Global Recombinant FSH Sales Growth Rate (2012-2017)102
Figure Global Recombinant FSH Price (2012-2017) (USDDose)103
Figure Global Urinary FSH Sales Growth Rate (2012-2017)104
Figure Global Urinary FSH Price (2012-2017) (USDDose)105
Table Global Follicle Stimulating Hormone Sales (K Doses) by Application (2012-2017)106
Table Global Follicle Stimulating Hormone Sales Share by Application (2012-2017)106
Figure Global Infertility Treatment Sales Growth Rate (2012-2017)107
Figure Global Assisted Reproductive Technology Sales Growth Rate (2012-2017)108
Figure Global Follicle Stimulating Hormone Sales (K Doses) and Growth Rate (2018-2023)109
Figure Global Follicle Stimulating Hormone Revenue (Million USD) and Growth Rate (2018-2023)110
Table Global Follicle Stimulating Hormone Sales (K Doses) Forecast by Regions (2018-2023)110
Table Global Follicle Stimulating Hormone Market Share Forecast by Regions (2018-2023)110
Figure North America Sales (K Doses) Follicle Stimulating Hormone Market Forecast (2018-2023)111
Figure Europe Sales (K Doses) Follicle Stimulating Hormone Market Forecast (2018-2023)112
Figure Asia-Pacific Sales (K Doses) Follicle Stimulating Hormone Market Forecast (2018-2023)113
Figure South America Sales (K Doses) Follicle Stimulating Hormone Market Forecast (2018-2023)114
Figure Middle East and Africa Sales (K Doses) Follicle Stimulating Hormone Market Forecast (2018-2023)115
Table Global Follicle Stimulating Hormone Sales (K Doses) Forecast by Type (2018-2023)115
Table Global Follicle Stimulating Hormone Market Share Forecast by Type (2018-2023)116
Table Global Follicle Stimulating Hormone Sales (K Doses) Forecast by Application (2018-2023)116
Table Global Follicle Stimulating Hormone Market Share Forecast by Application (2018-2023)116
Figure Marketing Channels of Follicle Stimulating Hormone121
Table DistributorsTraders Dealers List121

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top